Fecal Molecular Susceptibility-guided Hp First-line Therapy

NCT07405684 · clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
544
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Zhongshan Hospital